Viewing Study NCT07024550

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2025-12-29 @ 12:19 PM
Study NCT ID: NCT07024550
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-07-18
First Post: 2025-06-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Impact of the EXOMIND (BTL-699-2) on the Brain Reward Pathway
Sponsor: BTL Industries Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Binge Eating Behaviour View
None Binge Eating/Loss of Control Eating View
None Food Craving View
Keywords:

Keywords

Keyword Brief Keyword Text View
None brain reward pathway View
None fMRI View
None brain activity View
None rTMS View
None ExoTMS View
None EXOMIND View